Holen Sie sich die Stockscreener-App
28.49
1.06%
0.27
Finanzdaten der Apellis Pharmaceuticals Inc-Aktie (APLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.01%
178.49
|
166.80 | 212.53 | 196.83 | 199.69 |
Operating Expenses
|
15.33%
211.78
|
250.12 | 238.69 | 244.11 | 229.13 |
| Benefits Costs and Expenses |
14.88%
220.18
|
258.68 | 248.59 | 253.68 | 237.23 |
| Costs And Expenses |
14.88%
220.18
|
258.68 | 248.59 | 253.68 | 237.23 |
| Operating Income/Loss |
60.05%
-33.29
|
-83.33 | -26.16 | -47.28 | -29.44 |
| Income/Loss From Continuing Operations Before Tax |
54.63%
-41.69
|
-91.88 | -36.07 | -56.85 | -37.54 |
| Income Tax Expense/Benefit |
36.66%
0.466
|
0.341 | 0.286 | 0.592 | 0.114 |
| Income/Loss From Continuing Operations After Tax |
54.30%
-42.15
|
-92.22 | -36.35 | -57.45 | -37.66 |
|
Net Income/Loss
|
54.30%
-42.15
|
-92.22 | -36.35 | -57.45 | -37.66 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.46%
126.02
|
125.45 | 0.207 | 124.23 | 123.90 |
| Diluted Average Shares |
0.46%
126.02
|
125.45 | 0.207 | 124.23 | 123.90 |
| Basic Earnings Per Share |
55.41%
-0.33
|
-0.74 | -0.29 | -0.46 | -0.30 |
| Diluted Earnings Per Share |
55.41%
-0.33
|
-0.74 | -0.29 | -0.46 | -0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.31%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):